AVBP vs SBAC · $1.39B cap vs P/E 30, rev $1.42B
ArriVent BioPharma, Inc. Common Stock (AVBP) versus SBA Communications Corp (SBAC) — a side-by-side from cached financials, not a winner call.
ArriVent BioPharma, Inc. Common Stock (AVBP) is a biotechnology company listed on US.
SBA Communications Corp (SBAC) is a reit - specialty company listed on US.
AVBP does not have a complete income-statement cache yet.
Latest reported SBAC revenue for 2026-06-30 was $1.42B. Net income was $383.6M. SBAC currently screens at market cap $24.58B and trailing P/E 30.3.
AVBP currently screens at market cap $1.39B. SBAC currently screens at market cap $24.58B and trailing P/E 30.3.
Not investment advice. Open the AVBP and SBAC stock pages for the full models.
Not investment advice.